Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease.
about
Identification and initial characterization of four novel members of the interleukin-1 familyThe ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for herpes simplex virus types 1 and 2 in human cellsNectin2alpha (PRR2alpha or HveB) and nectin2delta are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein DThe molecular basis of herpes simplex virus latencyMode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virusEffect of acycloguanosine treatment of acute and latent herpes simplex infections in miceMode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cellsAntiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in animalsPathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivoComparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression modelValacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.Herpes simplex virus genome isomerization: origins of adjacent long segments in concatemeric viral DNA.Isolation of herpes simplex virus from the cornea in chronic stromal keratitis.Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study.Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovirCell surface expression of H2 antigens on primary sensory neurons in response to acute but not latent herpes simplex virus infection in vivoProtective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant.Tracking the spread of a lacZ-tagged herpes simplex virus type 1 between the eye and the nervous system of the mouse: comparison of primary and recurrent infectionEffect of immunosuppression on recurrent herpes simplex in mice.Pathogenicity of wild-type and temperature-sensitive mutants of herpes simplex virus type 2 in guinea pigs.A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neuronesPersistence of infectious herpes simplex virus type 2 in the nervous system in mice after antiviral chemotherapyOrofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment.B cell response to herpesvirus infection of the olfactory neuroepithelium.Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNAOAS and PKR are not required for the antiviral effect of Ad:IFN-gamma against acute HSV-1 in primary trigeminal ganglia cultures.Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.PrP(c) expression influences the establishment of herpes simplex virus type 1 latency.Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts.Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1.Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system.The HSV-1 Latency-Associated Transcript Functions to Repress Latent Phase Lytic Gene Expression and Suppress Virus Reactivation from Latently Infected NeuronsAn animal model of ocular herpes. Keratitis, retinitis and cataract in the mouse.Neural changes in recurrent genital infection of infectious bovine rhinotracheitis virus in calves treated with dexamethasone.Structural variability of the herpes simplex virus 1 genome in vitro and in vivo.Influence of herpes simplex virus 1 latency-associated transcripts on the establishment and maintenance of latency in the ROSA26R reporter mouse modelAnti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neuronsThe pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice.In vivo reactivation of herpes simplex virus in rabbit trigeminal ganglia: electrode model.Pathogenesis of Herpes simplex virus infections in guinea pigs.
P2860
Q22253413-CA710140-FB32-4D07-9C0F-B12227F65618Q24523691-40DAF1C7-C607-44D7-A8AC-9BE50C409F7FQ24524264-95783BA2-E5D9-4BE5-B78E-07CAD261DC97Q27001272-CF56BAFA-06AE-4DF6-970F-B3B1D60276A2Q28327167-27E2D5A7-3779-4CF2-80A6-6610493CE78CQ28327450-6CED9985-9BD8-4EF6-9CB9-F45D50CC8E17Q28342540-61C9072D-3A41-416E-B6AD-4614826494CCQ28361450-E950085E-CAC1-4FFF-9E9A-E5BD02A233B9Q28366019-3F6FE0EC-6CA1-49B4-8A35-75C518123517Q28367893-1D8BC164-E18A-4854-8470-76D47D575D69Q30979930-FE1EB48D-B4FC-4922-B0AF-E92525A706D7Q33639905-77C5CA60-11F7-44A5-B6C0-11792CDCEAB3Q33642198-A4B7A670-E463-4D88-830B-67DD1EC452F8Q33693860-243AB47B-57BC-4BA9-A152-2CB583896237Q33739521-CF5101C4-124F-453B-A98F-9922A4C6E60FQ33816955-95A27782-384C-4475-B6B7-0BE38D223059Q33837275-5AFFE710-86A2-4694-996D-B5CB605151A1Q33851936-680AA490-A01A-4480-B6A6-D9717C8CE2FCQ33907530-226EF582-3E4B-4DA9-B298-6A5C6A398FAEQ33909054-E74D3962-FCAE-4BEF-9462-3B62C1B948BBQ33910593-6FD0B964-B7A4-454A-8D6C-5306CC580522Q33978465-7EC67ED2-E9AC-44B4-B66F-9471AC221B0FQ34433035-F9DB01D1-9AFA-4DE0-80F0-B73B1A7A4551Q34594943-5446FF0E-1B69-4AC8-94D1-D8074BF8952EQ34648195-5CF2F84F-8E94-48C5-A5F6-8FAC0D5CACC8Q34649192-F76807C0-6DF0-46B6-BF68-0170ECBF00E4Q34729783-0D17D5D3-AA0E-4D8C-9C13-4DBAA1C374D8Q34969580-0E9F9993-E71B-4C9D-8464-B00E63930C4BQ35024312-13965CBC-0563-4C19-B2CD-F2A621E06227Q35844818-0D9B86FD-9382-4564-BA2A-B016D057099EQ35881379-DD630C2C-E043-4ADD-A7CC-6A81C17A66FBQ35982911-C244E92F-66D5-449D-92EF-704A77E1EC94Q36090324-6AFDA262-083E-479A-92C1-5191364F13C9Q36091140-4626D462-54D4-4EC8-A541-2B9B39F71447Q36172069-00B62BCB-A6F5-4706-8E36-3F6691E5D686Q36172119-6CD4244E-48F7-46F4-B277-217AA2C9C8D8Q36231298-E8C74D81-5A20-484F-9EF9-5373937F3B4BQ36250741-B3874E66-4C9A-429A-8C11-56349069D022Q36428487-0E29BB24-0D4D-4CA7-8FDE-CAF0717F0641Q36431209-5778B1A5-54D8-482B-BDF3-A32E4BAA6208
P2860
Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh
1975年學術文章
@zh-hant
name
Acute and recurrent infection ...... latency and recurrent disease.
@en
Acute and recurrent infection ...... latency and recurrent disease.
@nl
type
label
Acute and recurrent infection ...... latency and recurrent disease.
@en
Acute and recurrent infection ...... latency and recurrent disease.
@nl
prefLabel
Acute and recurrent infection ...... latency and recurrent disease.
@en
Acute and recurrent infection ...... latency and recurrent disease.
@nl
P2093
P1476
Acute and recurrent infection ...... latency and recurrent disease.
@en
P2093
P304
P356
10.1099/0022-1317-28-3-341
P407
P577
1975-09-01T00:00:00Z